Technological innovations throughout the past several decades have transformed the pharmaceutical manufacturing process from traditional batch production to ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...